Facilitators and barriers to medication adherence with adjuvant endocrine therapy in women with breast cancer: a structural equation modelling approach

被引：0
|
作者：
Eng Hooi Tan
Andrea Li Ann Wong
Chuan Chien Tan
Patrick Wong
Sing Huang Tan
Li En Yvonne Ang
Siew Eng Lim
Wan Qin Chong
Jingshan Ho
Soo Chin Lee
Bee Choo Tai
机构：
[1] National University of Singapore and National University Health System,Saw Swee Hock School of Public Health
[2] NUHS,Department of Haematology
[3] Ng Teng Fong General Hospital,Oncology, National University Cancer Institute
[4] NUHS,Department of General Surgery
[5] OncoCare Cancer Centre,Division of Oncology Pharmacy, National University Cancer Institute
[6] National University of Singapore and National University Health System,Yong Loo Lin School of Medicine
来源：
Breast Cancer Research and Treatment | 2021年 / 188卷
关键词：
Adjuvant endocrine therapy; Adherence; Breast cancer; Necessity-concerns framework; Structural equation modelling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：779 / 788
页数：9
相关论文
共 50 条
  • [41] Safety of Adjuvant Endocrine Therapy in Postmenopausal Women With Breast Cancer
    Abdulhaq, Haifaa
    Geyer, Charles
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (06): : 595 - 605
  • [42] Adjuvant endocrine therapy for perimenopausal women with early breast cancer
    Ortmann, Olaf
    Cufer, Tanja
    Dixon, J. Michael
    Maass, Nicolai
    Marchetti, Paolo
    Pagani, Olivia
    Pronzato, Paolo
    Semiglazov, Vladimir
    Spano, Jean-Philippe
    Vrdoljak, Eduard
    Wildiers, Hans
    [J]. BREAST, 2009, 18 (01): : 2 - 7
  • [43] Adjuvant endocrine therapy for premenopausal women with early breast cancer
    Dellapasqua, S
    Colleoni, M
    Gelber, RD
    Goldhirsch, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) : 1736 - 1750
  • [44] Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer
    Koeberle, Dieter
    Thuerlimann, Beat
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (01) : 5 - 10
  • [45] Persistence and discontinuation of adjuvant endocrine therapy in women with breast cancer
    Sayaka Kuba
    Mayumi Ishida
    Yoshiaki Nakamura
    Kenichi Taguchi
    Shinji Ohno
    [J]. Breast Cancer, 2016, 23 : 128 - 133
  • [46] Adjuvant endocrine therapy for premenopausal women with early breast cancer
    Ting Bao
    Nancy E Davidson
    [J]. Breast Cancer Research, 9
  • [47] Persistence and discontinuation of adjuvant endocrine therapy in women with breast cancer
    Kuba, Sayaka
    Ishida, Mayumi
    Nakamura, Yoshiaki
    Taguchi, Kenichi
    Ohno, Shinji
    [J]. BREAST CANCER, 2016, 23 (01) : 128 - 133
  • [48] Adherence to adjuvant endocrine therapy for breast cancer: women's experiences of taking tamoxifen, letrozole and anastrozole
    Harrow, A.
    Dryden, R.
    McCowan, C.
    Radley, A.
    Parsons, M.
    Thompson, A. M.
    Wells, M.
    [J]. EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2014, 18 : S12 - S13
  • [49] Non-adherence behaviors among young women on adjuvant endocrine therapy for breast cancer.
    Wassermann, Johanna
    Gelber, Shari I.
    Rosenberg, Shoshana M.
    Ruddy, Kathryn Jean
    Tamimi, Rulla M.
    Schapira, Lidia
    Borges, Virginia F.
    Come, Steven E.
    Partridge, Ann H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] Improving outcomes for women diagnosed with early breast cancer through Adherence to adjuvant endocrine therapy (SWEET)
    Sharp, Linda
    Watson, Eila
    Wells, Mary
    Horne, Rob
    Hiller, Louise
    Todd, Adam
    Wolstenholme, Jane
    Fenlon, Deborah
    Cahir, Caitriona
    Brett, Jo
    Hughes, Lyndsay
    Wardley, Andrew
    Nicholson, Brian
    Donnelly, Peter
    Rose, Jan
    Turner, Lesley
    Dunn, Janet
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 544 - 545
12345